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CBD, a precursor of THC 
in e‑cigarettes
Zsuzsanna Czégény1, Gréta Nagy1, Bence Babinszki1, Ákos Bajtel2, Zoltán Sebestyén1, 
Tivadar Kiss2, Boglárka Csupor‑Löffler3, Barbara Tóth2 & Dezső Csupor2,3*
The use of cannabidiol (CBD) in electronic cigarettes is widespread. Previously, it was reported that 
CBD is partly transformed to THC in case smoking as a cigarette, however, the pyrolysis of this 
compound has not been assessed extensively. The aim of our study was to investigate the effect of 
temperature on the composition of pyrolysis products of CBD. The experiments were performed in the 
typical operating temperature range of e‑cigarettes (250–400 °C) and at 500 °C under both inert and 
oxidative conditions, and the pyrolysis products were identified and quantified by GC–MS. Depending 
on the temperature and atmosphere, 25–52% of CBD was transformed into other chemical substances: 
Δ9‑THC, Δ8‑THC, cannabinol and cannabichromene were the predominant pyrolysates in both 
conditions, all formed by cyclization reaction. THC was the main pyrolysis product at all temperatures 
under both oxidative and inert conditions. Our results point out that CBD in e‑cigarettes can be 
considered as a precursor of THC, thus it bears all the dangers related to this psychoactive compound. 
Our findings are fundamental contributions to the safety profile of CBD‑based e‑cigarettes.
In recent years, the consumption of Cannabis sativa-based products has been on the rise. The main bioactive 
compounds of the plant are phytocannabinoids, more than 110 of which have been identified so  far1. (−)-trans-
Δ9-Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the major substances of Cannabis, the former 
known for its psychoactivity. Due to the widespread use of the plant for recreational purposes, plant breeding 
aimed at production of plant material rich in THC for decades. Nowadays, it seems like that the focus has been 
shifted from THC to CBD, since there is a growing demand from the food supplement industry for THC-free 
extracts with CBD as the major constituent. Cannabidiol (CBD) is a non-psychoactive compound possessing 
several supposed and proved beneficial health effects.
In the US, a record-breaking increase in CBD sales was generated in the past 2 years. In general, oils, tinctures, 
soft gels as well as liquids are found to be the most widely used forms for CBD preparations. Approximately 
one fifth of the US population have used some type of CBD related products in recent  years2. Flowers, leaves, 
seeds from the cannabis plant are known to have traditionally been used as anti-inflammatory, pain relieving, 
antidepressant, and anticonvulsant  remedies3. Authorities both in the EU and USA have lately approved the CBD-
containing medicine  Epidiolex® for treating children of age two or older with severe epileptic seizures. However, 
the current rise of Cannabis is only partly related to the medicinal use of CBD. Most of the CBD-containing 
products are marketed as food supplements.
Besides medical and food use, other CBD formulations, including liquids for electronic cigarettes, have also 
emerged. The popularity of these liquids is increasing. In the Washington State area, cannabis extracts used for 
inhalation possessed 21.2% of the purchases, which was almost one and a half times higher in 2016 than it was in 
 20144. Despite the safety claims of e-cigarettes, in some cases the appearance of lung injuries by vaping e-liquids 
containing CBD as an additive were reported. The possibly harmful pyrolysis products could have toxic effects 
in the human  body5. Moreover, the evaporated CBD itself might increase the risk of cardiovascular  events6.
Lawfully produced CBD products are available in the European Union but not all member states allow the 
distribution of them. In a French court decision, company directors from the Czech Republic were sentenced 
to suspended imprisonment for marketing electronic cigarette cartridges in France. Legislative authorities in 
France could prohibit the marketing of Cannabis sativa extracts based on the narcotic hallmark of CBD, thus 
labeling distributors as  criminals7, even though CBD itself is not psychoactive and is not reckoned as a controlled 
substance by the UN Commission on Narcotic Drugs.
Smoking or using e-cigarette exposes compounds to temperatures sufficient to promote chemical reactions, 
modifying the composition of the smoke this way. It has been reported even in the 1970’s that CBD is partly 
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transformed to THC in case smoking as a  cigarette8. This was reassured later in pyrolysis studies performed at 
700 °C9 or under simulated smoking  conditions10, however, this pyrolysis reaction has not been studied exten-
sively. The widespread use of CBD in e-cigarettes necessitates quantitative data on the pyrolytic transformation 
of CBD at lower pyrolysis temperatures. The aim of our research work presented here was to analyze the pyrolysis 
products of CBD by adopting standard heating conditions used in electronic  cigarettes11,12, with special focus 
on THC.
Results
Depending on e-liquid fill level, coil resistance and voltage settings, the coil temperatures of e-cigarettes ranges 
from 110 to 1008 °C11,13. Typical wetted coil temperature is 200–400 °C, extremely high temperatures (around 
1000 °C) have been measured for dry coils without any e-liquid14. In our experiments, we studied pyrolysis in 
the typical operating temperature range of e-cigarettes (250–400 °C) under both inert and oxidative conditions. 
Additional experiments were performed at 500 °C in both atmospheres to test thermal degradation pattern at 
elevated temperatures.
The composition of CBD pyrolysates obtained in inert and oxidative atmospheres are summarized in Tables 1 
and 2, respectively. The obtained data clearly present the thermal instability of CBD. Depending on the tempera-
ture and atmosphere, 25–52% of CBD transformed into other chemical substances during the experiments. In the 
absence of oxygen, 23 pyrolysis products were observed, 15 of which were identified (see Table 1). These com-
pounds represented 81–97% of the pyrolysis products (at lower temperatures, between 250–400 °C, 93–97%). In 
the presence of oxygen, 22 pyrolysis products were detected (see Table 2), the identified 15 components represent 
the 88–96% of the degradation products in the studied temperature range. Most of the degradation products (i.e. 
18 compounds) appeared among both inert and oxidative conditions. Additional four products were observed 
exclusively in oxidative, while five degradation products exclusively in inert atmosphere.
The four most intense products, namely Δ9-THC, Δ8-THC, cannabichromene and cannabinol account for 
more than 95% of the decomposition products at 250 and 300 °C pyrolysis temperatures in inert atmosphere. 
Under oxidative conditions an additional product, cannabielsoin appeared. The ratio of the aforementioned five 
decomposition products is more than 80% under oxidative conditions up to 300 °C. All of these compounds 
Table 1.  Product distribution of CBD at various temperatures in inert atmosphere. Percentages are calculated 
using peak areas of the total ion current chromatograms. n.d. below detection limit, tR retention time, MW 
molecular weight. a Compound ID number. b Unidentified compounds which appear in both inert and oxidative 
conditions.
No. No.a Compound tR (min) Mw (g/mol)
I 250 °C I 300 °C I 400 °C I 500 °C
Mean (%) SD (%) Mean (%) SD (%) Mean (%) SD (%) Mean (%) SD (%)
1 2 p-Mentha-1,3,8-triene 12.88 134 n.d n.d 1.08 0.35 n.d
2 3 p-Mentha-1,5,8-triene 13.23 134 n.d n.d 1.34 0.05 1.70 0.36
3 4 p-Cymene 13.31 134 n.d n.d n.d 1.93 0.13
4 5 p-Cymenene 14.78 132 n.d n.d n.d 0.48 0.14
5 6 p-Mentha-1,4,8-triene 14.88 134 n.d n.d n.d 1.83 0.48
6 8 Olivetol 26.43 180 n.d n.d 0.50 0.19 2.25 0.45
7 9 2,2-Dimethyl-7-pentyl-2H-chromen-5-ol 27.21 246 n.d n.d n.d 1.00 0.51
8 10 Cannabicyclol 29.74 314 0.12 0.02 n.d 0.29 0.11 0.38 0.01
9 11 Unidentified 29.83 314 0.15 0.04 n.d 0.12 0.02 0.22 0.08
10 12 Unidentified  Ab 29.98 312 0.14 0.03 n.d 0.30 0.08 1.97 0.25





30.28 314 0.39 0.06 0.15 0.03 0.33 0.12 0.75 0.07
13 15 Unidentified 30.45 312 n.d n.d n.d 0.44 0.03
14 16 5-Pentyl-2-(4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-yl)benzene-1,3-diol 30.51 314 0.50 0.04 n.d 0.40 0.23 1.42 0.11
15 18 Unidentified  Bb 30.62 312 n.d 0.18 0.07 0.33 0.17 0.32 0.07
16 19 Cannabichromene 30.73 314 7.00 0.49 3.17 0.94 5.64 1.76 2.35 0.54
17 20 CBD 30.82 314 48.20 5.13 74.62 4.40 62.11 9.53 67.66 5.51
18 21 Unidentified  Cb 31.10 314 0.56 0.06 0.62 0.18 0.70 0.12 1.07 0.16
19 22 Unidentified  Db 31.17 314 0.45 0.02 n.d 0.46 0.10 0.88 0.22
20 23 Δ8-THC 31.25 314 4.94 0.67 1.64 0.32 2.73 0.68 2.76 0.63
21 24 Δ6a,10a-THC 31.39 314 n.d n.d n.d 1.36 0.29
22 25 Δ9-THC 31.49 314 33.94 4.07 17.95 2.96 20.17 4.42 5.88 1.57
23 27 Unidentified  Eb 31.82 314 n.d n.d n.d 0.53 0.07
24 28 Cannabinol 32.41 310 3.64 0.07 1.66 0.33 3.49 1.49 2.25 0.21
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Table 2.  Product distribution of CBD at various temperatures in oxidative atmosphere. Percentages are 
calculated using peak areas of the total ion current chromatograms. n.d. below detection limit, tR retention 
time, MW molecular weight. a Compound ID number. b Unidentified compounds which appear in both inert 
and oxidative conditions.
No No.a Compound tR (min) Mw (g/mol)
O 250 °C O 300 °C O 400 °C O 500 °C
Mean (%) SD (%) Mean (%) SD (%) Mean (%) SD (%) Mean (%) SD (%)
1 1 Unidentified monoterpene 11.62 134 n.d n.d 0.42 0.07 n.d
2 2 p-Mentha-1,3,8-triene 12.76 134 0.94 0.15 1.37 0.65 0.64 0.18 n.d
3 3 p-Mentha-1,5,8-triene 13.17 134 1.00 0.04 1.16 0.52 1.70 0.07 3.64 0.62
4 4 p-Cymene 13.32 134 n.d n.d n.d 2.87 0.45
5 5 p-Cymenene 14.83 132 n.d n.d 0.47 0.19 1.61 0.69
6 6 p-Mentha-1,4,8-triene 14.92 134 n.d n.d 1.30 0.41 3.60 1.09
7 7 6-Pentylbenzofuran-4-ol 25.99 204 n.d 0.28 0.11 n.d n.d
8 8 Olivetol 26.46 180 n.d 0.21 0.07 0.76 0.21 n.d
9 10 Cannabicyclol 29.74 314 1.08 0.27 0.21 0.07 0.64 0.13 0.44 0.10





30.28 314 0.23 0.05 0.34 0.04 0.68 0.17 n.d
12 16 5-Pentyl-2-(4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-yl)benzene-1,3-diol 30.51 314 0.11 0.02 n.d 0.72 0.42 n.d
13 17 Unidentified 30.54 312 0.19 0.04 0.78 0.10 1.75 2.40 n.d
14 18 Unidentified  Bb 30.61 312 0.26 0.05 0.58 0.16 0.19 0.05 n.d
15 19 Cannabichromene 30.73 314 5.03 0.95 5.74 0.59 5.32 0.67 2.36 1.05
16 20 CBD 30.81 314 62.02 5.09 61.58 2.95 52.19 6.56 64.41 9.98
17 21 Unidentified  Cb 31.10 314 0.74 0.13 1.04 0.14 1.27 0.29 n.d
18 22 Unidentified  Db 31.15 314 n.d 0.52 0.07 0.72 0.18 n.d
19 23 Δ8-THC 31.25 314 3.57 0.74 2.54 0.23 3.38 0.73 2.10 0.66
20 25 Δ9-THC 31.48 314 16.09 3.96 12.85 0.86 13.45 2.38 8.55 3.77
21 26 Cannabielsoin 31.50 330 3.44 0.14 3.83 0.50 2.56 0.27 2.89 0.68
22 27 Unidentified  Eb 31.81 314 n.d n.d 0.39 0.02 1.63 0.56
23 28 Cannabinol 32.41 310 5.00 0.34 6.56 0.49 10.44 0.82 5.59 2.55
Figure 1.  The major thermal decomposition routes of CBD in inert (helium) and oxidative (9% oxygen in 
nitrogen) atmosphere in a temperature range of 250–500 °C.
4
Vol:.(1234567890)
Scientific Reports |         (2021) 11:8951  | https://doi.org/10.1038/s41598-021-88389-z
www.nature.com/scientificreports/
formed by cyclization reaction (see Fig. 1). Cyclization of phenolic flavors to bicyclic compounds under simulated 
tobacco heating conditions at 300 °C was reported  earlier15. The phenolic O of thymol or ethylvanillin link to a 
geometrically favorable position of a sterically adjacent side group of the molecule, forming a bicyclic compound. 
Analogously, in the present case one of the phenolic O of CBD linked to the tertiary carbon of the isopropenyl 
group, thus forming a sterically favored six-membered ring and resulting Δ9-THC molecule. However, Δ9-THC 
formed also under inert atmosphere. The related cyclization can be formally described as an intramolecular 
Markovnikov addition of the phenolic OH onto the double bond of the isopropenyl group. Thus, no oxida-
tion step is needed by the formation of Δ9-THC. The psychoactive Δ9-THC was the main detected compound, 
accounting up to 42% and 70% of the decomposition products under oxidative and inert conditions, respectively, 
at all applied temperatures. One possible reason of the lower Δ9-THC amount in oxidative atmosphere measured 
in our study could be the higher decomposition rate of the formed Δ9-THC in the oxidative ambient. Increased 
degradation rate of Δ9-THC was published in cannabis resin sample exposed to air comparing to that of stored 
in a sealed plastic bag at ambient  temperature16 indicating the role of oxygen in Δ9-THC decomposition.
Among THC isomers, Δ8-THC has also psychotropic effects according to the recent review of the Expert 
Committee on Drug Dependence of the World Health Organization (WHO)17. The Δ8-THC molecule formed 
by an additional isomerization to the cyclization during thermal treatment. Both Δ9-THC and Δ8-THC were 
formed at higher rate in inert atmosphere and at relative lower temperatures (250–300 °C). By increasing the 
temperature, the relative yield of THC decreased, while other decomposition reactions became more pronounced.
According to earlier studies, cannabinol derives by cyclization, dehydration, and aromatization of CBD, 
probably through a THC intermediate during long-term  storage16. Notable amount of cannabinol was detected 
in the present study as a thermal degradation product of CBD. The relative amount of cannabinol was signifi-
cantly higher in oxidative conditions at each studied temperature, indicating the effect of oxygen in the reaction 
mechanism. In addition to the driving force of the aromatization in both atmospheres, dehydrogenation by 
oxygen with water elimination may play additional role in oxidative atmosphere. The most intense cannabinol 
formation (10.4%) was observed at 400 °C in oxidative atmosphere.
Cannabichromene also formed through cyclization reaction. However, one of the phenolic O of the CBD 
molecule attacked the double bond of the cyclohexene ring at C substituted with methyl group in this case, while 
the cyclohexene ring opened up by C–C scission to form the chromene frame. Formation of cannabichromene 
was more pronounced in inert atmosphere compared to the oxidative condition at 250 °C. At higher temperatures 
there was no significant difference and the relative yield of cannabichromene was decreased.
Cannabielsoin was only detected under oxidative conditions. In this transformation, one of the phenolic O of 
CBD linked similarly to the double bond of its cyclohexene ring, but at the secondary carbon, while a hydroxyl 
group formed at the adjacent C substituted with methyl group via the oxidative medium. The relative intensity 
of cannabielsoin was around 3%, and its quantity was not much affected in the temperature range of 250–500 °C.
At higher temperatures, the share of the decomposition products formed through cyclization reaction was 
decreased, while the relative intensity of smaller molecules formed by C–C bond scission increased in the pyro-
lyzate. These identified products were formed by the scission of the bond connecting the pentylbenzenediol and 
the p-mentha-1,8-dienyl moieties of the CBD molecule. Menthatriene isomers appeared at 250 °C in oxidative 
atmosphere, while in inert atmosphere only above 400 °C, indicating that the presence of oxygen promoted the 
cleavage of the molecule. The relative amount of menthatrienes were the highest at 500 °C in both inert and 
oxidative atmospheres.
Discussion
Here we present the first extensive analysis of the pyrolysis of CBD under conditions relevant in case of using 
the substance in e-cigarettes. THC was the main pyrolysis product at all temperatures under both oxidative and 
inert conditions. The typical THC content (the integer number closest to the median values) of joints used for 
recreational purposes is around 7  mg18. A Swiss analysis based on 20 samples found that the total CBD content 
of e-liquids ranged between 0.182 and 3.346% and differed in half of the samples from the claimed  content19. 
According to a study, two e-liquids were labeled to contain 3.3 mg/mL of CBD, however they were found to 
contain 6.5 and 7.6 mg/mL of  CBD20. On the basis of our results, it might be assumed that up to 0.5–1 mg of 
THC may be intaken by vaping each mL of CBD-containing e-liquid. However, it should be mentioned that the 
applied experimental method revealed the thermal degradation of pure CBD. Therefore, the possible effect of 
the vaping fluid (e.g. PG/VG20) on the stability and breakdown pattern was not taken into consideration. Nev-
ertheless, due to the observed high conversion rate of CBD to THC, the results highly draw attention on the risk 
of CBD-containing e-liquids. The heating time in an e-cigarette may vary depending on its type and customer 
habit. Despite the relatively long isothermal period (5 min) applied in the pyrolysis method, a short residence 
time in the hot zone of the pyrolyzer is expected, because the boiling point of CBD and its degradation products 
is relatively low (155–185 °C) and high flow rate (276 mL/min) was applied during pyrolysis.
Recently, the incidence of the so-called vaping-associated pulmonary illness (VAPI) has been increasing (this 
condition is also known as EVALI, e-cigarette or vaping product use-associated lung injury). Until February 
2020, more than 2800 patients had been hospitalized in the US due to VAPI, with a total of 68 deaths reported 
21. Although the etiology of VAPI has not been elucidated yet, nicotine, THC, CBD, and vitamin E are among 
the most suspected ingredients with a link to the pathogenesis of the disease 22.
The presence of CBD in e-cigarettes might pose dual risk. First, as a precursor of the psychoactive THC, it 
bears all the dangers related to THC use. Consumers of CBD-containing e-cigarettes may also be involuntarily 
exposed to the psychoactive THC. Moreover, its use in e-cigarette liquids is not regulated; therefore, the exposure 
of e-cigarette users to THC is unknown. And second, CBD itself is a pharmacologically active compound with 
remarkable activities on the central nervous and the cardiovascular system and is marketed as prescription-only 
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medicine with several potential adverse effects such as somnolence, decreased appetite, diarrhea, pyrexia, fatigue, 
and  vomiting23.
The results presented here might be important contributions to the legal discretion of CBD. Although accord-
ing to the French law, the distribution of CBD-containing e-cigarette cartridges was considered as infringe-
ments of the legislation on poisonous substances, the Court of Justice of the European Union had a different 
 interpretation24. Albeit CBD itself is void of psychoactivity, our results underline, that remarkable amount of THC 
might be formed from CBD during evaporation in an e-cigarette. Therefore, the standpoint, that CBD does not 
appear to have any psychotropic effect or any harmful effect on human health on the basis of available scientific 
data, should be reconsidered. From a scientific point of view, when used in an e-cigarette, CBD is the precursor 
of THC, although this fact is not reflected yet in drug policy and legislation.
Methods
A 1 mg/mL CBD in methanol solution was purchased from Supelco (certified reference material, Cerilliant), and 
kept at − 20 °C till the analysis. The experiments were performed either in a gas mixture of 9.34% (n/n) oxygen 
and 90.66% (n/n) nitrogen or in helium atmosphere.
The experimental method to simulate the low-temperature tobacco heating conditions was developed in our 
earlier  study12. This method was adopted and modified by using various  temperatures11 to study the breakdown 
pattern of CBD; therefore, the experimental conditions are described here briefly.
Py-GC/MS analyses have been carried out using a Pyroprobe 2000 (CDS Analytical, Oxford, PA, USA) 
pyrolyzer equipped with a platinum heating coil and a quartz sample tube. A total 15 µL aliquot of solution was 
dispensed in 5 µL portions onto a piece of quartz wool placed in the quartz tube and it was rested for 3 min at 
room temperature to allow evaporating the majority of the solvent after each portion. The quartz tube was placed 
in the Pyroprobe, at room temperature, which was then inserted into the pre-heated pyrolysis chamber. The 
temperature of the pyrolysis chamber was 280 °C, except in case of pyrolysis experiments performed at 250 °C, 
when the chamber temperature was set at 250 °C as well. The pyrolysis chamber was flushed at a 276 mL/min 
flow rate by the applied gas mixture. The sample was then heated at a maximal heating rate (set at 999 °C/s) to 
the final pyrolysis temperature. The experiments were performed at five different pyrolysis temperatures in a 
temperature range of 250–500 °C, using 5 min isotherm period in the case of each pyrolysis temperature. Oxida-
tive experiments were performed in a gas mixture of 9% oxygen and 91% nitrogen. In order to reveal the role 
of oxygen in the thermal degradation reactions, additional experiments were performed in helium atmosphere, 
applying the same pyrolysis temperatures. The volatile products were purged on-line to a DB-1701 capillary 
column (30 m × 0.25 mm i.d., 0.25 µm film thickness) of the GC/MS (Agilent 6890 GC/5973 MSD) system. At 
the end of the pyrolysis, the pyrolysis gas flow was closed, and helium carrier gas was supplied to the GC/MS. 
Solvent delay of 7 min was applied to protect the MS. The GC oven was programmed to 7 min isotherm period 
at 40 °C before increase to 280 °C at a rate of 10 °C/min. The range of m/z 29–400 was scanned by the mass 
spectrometer in EI mode (70 eV). At least three parallel experiments were performed at each temperature. The 
identification of the pyrolysis products (see Supplementary Table S1) was based on the combined Wiley Registry 
9th edition/NIST 2011 mass spectral library and literature  data25–29. The percentages of the compounds were 
estimated using the peak areas of the total ion current chromatograms.
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